Almost 50% of adults living with type 1 diabetes experience high levels of diabetes distress
News
Celebrating the 2024 PharmaTimes MSEA and NIEA awards
The awards celebrated both medical affairs and nursing professionals in the industry
Innovate UK grants £4m to four companies to evaluate biomarkers for dementia
The progressive neurodegenerative disease affects more than 55 million people globally
UK Researchers developing new tetanus test to identify global immunity gaps
The serious, rare condition is responsible for up to 7% of all neonatal deaths globally
Researchers awarded £1.5m for national dementia inequalities network
The ESRC EquaDem Network Plus aims to improve disparities in diagnosis and care
New policy review reveals ten cancer challenges facing new UK government
Macmillan Cancer Support estimates that cancer affects over three million people in the UK
UK DRI and NHS collaborate on digitally enabled dementia care platform
Around one in five dementia hospitalisations are due to potentially preventable causes
Institutions to lead £1.7m-funded network to support people at risk of dementia
The neurodegenerative condition currently affects more than 944,000 people in the UK
Francis Crick and ICL spinout raises £90m to clinically develop cancer treatments
Myricx Bio’s therapies include treatments for breast, lung and colorectal cancer
SMC accepts Boehringer/Lilly’s Jardiance for CKD within NHS Scotland
The serious, progressive kidney disease affects nearly 850 million people worldwide
Coloplast launches digital leakage notification system Heylo for stoma patients
More than 176,000 people in the UK are living with a stoma, according to NHS data
Mission awarded $5.2m to advance potential Parkinson’s treatment
The progressive neurodegenerative condition affects around 153,000 people in the UK
Study reveals mobile phone data can help map the spread of pathogens
Pneumococcus is the leading cause of pneumonia, meningitis and sepsis worldwide
NeuroSense Therapeutics shares positive results of lead candidate in ALS
The neurodegenerative disease currently affects more than 200,000 people worldwide
Study reveals genetic mutations associated with aggressive prostate cancer
Aggressive prostate cancer accounts for up to 15% of all prostate cancer diagnoses
